Showing results (241-250 of 297) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinomaMark J Ratain, Tim Eisen, Walter M Stadler, et al.
Therapeutic Advances in Medical Oncology|January 8, 2021
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trialNatalie Reizine, Everett E Vokes, Ping Liu, et al.
Pharmacogenetics and Genomics|June 21, 2021
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)Jai N Patel, Chen Jiang, Kouros Owzar, et al.
The AAPS Journal|June 17, 2017
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)Shailly Mehrotra, Manish R Sharma, Elizabeth Gray, et al.
Clinical Pharmacology and Therapeutics|February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen TherapyMatthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeChanning J Paller, Penelope A Bradbury, S Percy Ivy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patientsEzra E W Cohen, Kehua Wu, Christine Hartford, et al.
Springerplus|July 8, 2016
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancerRita Nanda, Erica M Stringer-Reasor, Poornima Saha, et al.
Annals of Internal Medicine|November 23, 2006
Pharmacogenomics: challenges and opportunitiesDan M Roden, Russ B Altman, Neal L Benowitz, et al.
Pharmacogenetics and Genomics|December 12, 2018
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation studyBrittany A Borden, Paige Galecki, Rebecca Wellmann, et al.
Pageof 30